MARK THOMAS WORTHINGTON, M.D.
Osteopathic Medicine at Ainsworth Dr, Prescott, AZ

License number
Arizona 43526
Category
Osteopathic Medicine
Type
Gastroenterology
License number
Arizona D40278
Category
Osteopathic Medicine
Type
Gastroenterology
Address
Address
810 Ainsworth Dr, Prescott, AZ 86301
Phone
(928) 771-5548
(928) 771-5549 (Fax)
(928) 759-5987
(928) 458-2039 (Fax)

Professional information

Mark T Worthington Photo 1

Dr. Mark T Worthington, Baltimore MD - MD (Doctor of Medicine)

Specialties:
Gastroenterology
Address:
Johns Hopkins Bayview Gas
4940 Eastern Ave, Baltimore 21224
(410) 550-0790 (Phone)
811 Ainsworth Dr STE 103, Prescott 86301
(928) 771-5548 (Phone)
Johns Hopkins Specialty Care
4924 Campbell Blvd STE 205, Nottingham 21236
(443) 442-2200 (Phone)
Johns Hopkins Specialty Care
4924 Campbell Blvd STE 205, Nottingham 21236
(443) 442-2290 (Phone)
Certifications:
Gastroenterology, 2004, Internal Medicine, 1991
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
Johns Hopkins Bayview Gas
4940 Eastern Ave, Baltimore 21224
Johns Hopkins Specialty Care
4924 Campbell Blvd STE 205, Nottingham 21236
Johns Hopkins Specialty Care
4924 Campbell Blvd STE 205, Nottingham 21236
811 Ainsworth Dr STE 103, Prescott 86301
Yavapai Regional Medical Center - West
1003 Willow Creek Rd, Prescott 86301
Education:
Medical School
Vanderbilt University School Of Medicine
Graduated: 1987
Johns Hopkins Hospital
Graduated: 1988
Graduated: 1990
Hohns Hopkins Hospital


Mark Worthington Photo 2

Methods And Compositions For Treating Or Preventing Autoimmune Diseases Using Immunomodulatory Agents

US Patent:
2012023, Sep 20, 2012
Filed:
Jul 23, 2010
Appl. No.:
13/386730
Inventors:
Adam Ian Kaplin - Baltimore MD, US
Mark T. Worthington - Prescott AZ, US
Assignee:
THE JOHNS HOPKINS UNIVERSITY - Baltimore MD
International Classification:
A61K 38/02, A61K 38/07, A61K 38/10, A61K 38/17, A61K 38/08, A61K 38/19, A61P 37/06, A61P 37/02, A61P 1/00, A61P 29/00, A61P 19/02, A61P 3/10, A61P 3/00, A61P 5/14, A61P 1/16, A61P 5/38, A61K 39/395
US Classification:
424 851, 4242781, 4241731, 4241331, 4241421
Abstract:
The present invention provides compositions and methods for treating and/or preventing an autoimmune disease comprising administering to a subject in need thereof an effective amount of cyclophosphamide and/or a cyclophosphamide derivative in combination with an additional immunomodulatory agent.